Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Brueggemann, Angela B ^a,b   Muroki, Beth Mbesu ^c   Kulohoma, Benard W ^c   Karani, Angela ^c   Wanjiru, Eva ^c   Morpeth, Susan ^b,c   Kamau, Tatu ^d   Sharif, Shahnaaz ^d   Scott, J Anthony G ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^d Ministry of Public Health and Sanitation   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; ALLELE; ARTICLE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; GENE IDENTIFICATION; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN TISSUE; KENYA; MAJOR CLINICAL STUDY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POPULATION GENETIC STRUCTURE; PRESCHOOL CHILD; PREVALENCE; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

GENES, BACTERIAL; GENETICS, POPULATION; HUMANS; KENYA; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE;

EID: 84896696314     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081539     Document Type: Article

References (53)

1. Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N et al. (2011) Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med 8: e1001017. PubMed: 21483718.
2. Centers for Disease Control and Prevention (CDC) (2005) Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. MMWR Morb Mortal Wkly Rep 54: 893-897. PubMed: 16163262.
3. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902. doi:10.1016/S0140-6736(09)61204-6. PubMed: 19748398.
4. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I et al. (2010) Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375: 1969-1987. doi:10.1016/S0140-6736(10)60549-1. PubMed: 20466419.
5. Centers for Disease Control and Prevention (CDC) (2013) Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2012. MMWR Morb Mortal Wkly Rep 62: 308-311. PubMed: 23615674.
6. Brent AJ, Ahmed I, Ndiritu M, Lewa P, Ngetsa C et al. (2006) Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study. Lancet 367: 482-488. doi:10.1016/S0140-6736(06)68180-4. PubMed: 16473125. (Pubitemid 43208904)
7. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E et al. (2005) Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 352: 39-47. doi:10.1056/NEJMoa040275. PubMed: 15635111. (Pubitemid 40075679)
8. Abdullahi O, Karani A, Tigoi CC, Mugo D, Kungu S et al. (2012) The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya. PLOS ONE 7: e30787. doi:10.1371/journal.pone.0030787. PubMed: 22363489.
9. Moïsi JC, Karani A, Kosi V, Lewa P, Mwarumba S et al. (2012) Secular trends in serotypes causing invasive pneumococcal disease in Kilifi, Kenya, 1994-2010. 8th International Symposium on Pneumococci and Pneumococcal Diseases, Brazil, Poster no. 101
10. De Wals P, Robin E, Fortin E, Thibeault R, Ouakki M et al. (2008) Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatr Infect Dis J 27: 963-968. doi:10.1097/INF.0b013e31817cf76f. PubMed: 18845982.
11. Rodenburg GD, de Greeff SC, Jansen AG, de Melker HE, Schouls LM et al. (2010) Effects of pneumococcal conjugate vaccine 2 years after its introduction, The Netherlands. Emerg Infect Dis 16: 816-823. doi: 10.3201/eid1605.091223. PubMed: 20409372.
12. Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K et al. (2009) Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 124: e1-11. doi:10.1542/peds.2008-3099. PubMed: 19564254.
13. Vestrheim DF, Høiby EA, Aaberge IS, Caugant DA (2010) Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway. Clin Vaccine Immunol 17: 325-334. doi:10.1128/CVI.00435-09. PubMed: 20107006.
14. Beall B, McEllistrem MC, Gertz RE, Wedel S, Boxrud DJ et al. (2006) Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J Clin Microbiol 44: 999-1017. doi:10.1128/JCM.44.3.999-1017.2006. PubMed: 16517889.
15. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W et al. (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 196: 1346-1354. doi:10.1086/521626. PubMed: 17922399. (Pubitemid 351412007)
16. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM et al. (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348: 1737-1746. doi:10.1056/NEJMoa022823. PubMed: 12724479. (Pubitemid 36514704)
17. (2010) Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report. Wkly Epidemiol Rec 85: 434-436. PubMed: 21038716.
18. Scott JR, Millar EV, Lipsitch M, Moulton LH, Weatherholtz R et al. (2012) Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities. J Infect Dis 205: 280-288. doi:10.1093/infdis/jir730. PubMed: 22128315.
19. Streptococcus pneumoniae MLST website. Available: http://spneumoniae. mlst.net/. Accessed 2013 Oct 26
20. Gertz RE, McEllistrem MC, Boxrud DJ, Li Z, Sakota V et al. (2003) Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol 41: 4194-4216. doi:10.1128/JCM.41.9.4194-4216.2003. PubMed: 12958247. (Pubitemid 37099686)
21. Active Bacterial Core surveillance (ABCs) website. Available: http://www.cdc.gov/abcs/index.html. Accessed 2013 Oct 26
22. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW et al. (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187: 1424-1432. doi:10.1086/374624. PubMed: 12717624. (Pubitemid 36549688)
23. Gonzalez BE, Hulten KG, Lamberth L, Kaplan SL, Mason EO Jr. (2006) Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J 25: 301-305. doi:10.1097/01.inf.0000207484.52850.38. PubMed: 16567980.
24. Gertz RE, Li Z, Pimenta FC, Jackson D, Juni BA et al. (2010) Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis 201: 770-775. doi:10.1086/650496. PubMed: 20178139.
25. Abdullahi O, Nyiro J, Lewa P, Slack M, Scott JA (2008) The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J 27: 59-64. doi:10.1097/INF.0b013e31814da70c. PubMed: 18162940.
26. Pai R, Gertz RE, Beall B (2006) Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 44: 124-131. doi:10.1128/JCM.44.1.124-131.2006. PubMed: 16390959.
27. Enright MC, Spratt BG (1998) A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144: 3049-3060. doi: 10.1099/00221287-144-11- 3049. PubMed: 9846740. (Pubitemid 28515583)
28. Saha SK, Darmstadt GL, Baqui AH, Hossain B, Islam M et al. (2008) Identification of serotype in culture negative pneumococcal meningitis using sequential multiplex PCR: implication for surveillance and vaccine design. PLOS ONE 3: e3576. doi:10.1371/journal.pone.0003576. PubMed: 18974887.
29. Francisco AP, Vaz C, Monteiro PT, Melo-Cristino J, Ramirez M et al. (2012) PHYLOViZ: Phylogenetic inference and data visualization for sequence based typing methods. BMC Bioinformatics 13: 87. doi: 10.1186/1471-2105-13-87. PubMed: 22568821.
30. Brueggemann AB, Spratt BG (2003) Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol 41: 4966-4970. doi:10.1128/JCM.41.11.4966-4970.2003. PubMed: 14605125.
31. Leimkugel J, Adams Forgor A, Gagneux S, Pflüger V, Flierl C et al. (2005) An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis 192: 192-199. doi:10.1086/431151. PubMed: 15962213. (Pubitemid 40993388)
32. Antonio M, Hakeem I, Awine T, Secka O, Sankareh K et al. (2008) Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: expansion of ST217 hypervirulent clonal complex in West Africa. BMC Microbiol 8: 198. doi: 10.1186/1471-2180-8-198. PubMed: 19014613.
33. Yaro S, Lourd M, Traoré Y, Njanpop-Lafourcade BM, Sawadogo A et al. (2006) Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso. Clin Infect Dis 43: 693-700. doi:10.1086/506940. PubMed: 16912941.
34. Brueggemann AB, Pai R, Crook DW, Beall B (2007) Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 3: e168. doi:10.1371/journal.ppat.0030168. PubMed: 18020702.
35. Beall BW, Gertz RE, Hulkower RL, Whitney CG, Moore MR et al. (2011) Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis 203: 1360-1368. doi:10.1093/infdis/ jir052. PubMed: 21398395.
36. Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG et al. (2005) Postvaccine genetic structure of Streptococcus pneumoniae serotype from children in the United States. J Infect Dis 192: 1988-1995. doi:10.1086/498043. PubMed: 16267772.
37. McGee L, McDougal L, Zhou J, Spratt BG, Tenover FC et al. (2001) Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol 39: 2565-2571. doi:10.1128/JCM.39.7.2565-2571.2001. PubMed: 11427569. (Pubitemid 32606233)
38. Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez MA et al. (2009) Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis 48: 57-64. doi:10.1086/597108. PubMed: 19035779.
39. Moore MR, Gertz RE, Woodbury RL, Barkocy-Gallagher GA, Schaffner W et al. (2008) Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197: 1016-1027. doi:10.1086/528996. PubMed: 18419539. (Pubitemid 351590031)
40. Reinert R, Jacobs MR, Kaplan SL (2010) Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine 28: 4249-4259. doi:10.1016/j.vaccine.2010.04.020. PubMed: 20416266.
41. Hodges RG, Mac LC (1946) Epidemic pneumococcal pneumonia; description of the epidemic. Am J Hyg 44: 183-192. PubMed: 21003015.
42. Robinson DA, Turner JS, Facklam RR, Parkinson AJ, Breiman RF et al. (1999) Molecular characterization of a globally distributed lineage of serotype 12F Streptococcus pneumoniae causing invasive disease. J Infect Dis 179: 414-422. doi:10.1086/314589. PubMed: 9878026. (Pubitemid 29086644)
43. Trust Kemri-Wellcome The Pneumococcal Conjugate Vaccine Impact Study (PCVIS) website. Available: http://www.kemri-wellcome.org/index.php/en/studies- inner/75. Accessed 2013 October 26
44. Finland M, Barnes MW (1977) Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J Clin Microbiol 5: 154-166. PubMed: 14971.
45. Loda FA, Collier AM, Glezen WP, Strangert K, Clyde WA Jr et al. (1975) Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J Pediatr 87: 1087-1093. doi:10.1016/S0022-3476(75)80120-X. PubMed: 241779.
46. Jefferies JM, Smith AJ, Edwards GFS, McMenamin J, Mitchell TJ et al. (2010) Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine. J Clin Microbiol 48: 87-96. doi:10.1128/JCM.01485-09. PubMed: 19923488.
47. Harboe ZB, Benfield TL, Valentiner-Branth P, Hjuler T, Lambertsen L et al. (2010) Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 50: 329-337. doi:10.1086/649872. PubMed: 20047478.
48. Melin M, Trzciñski K, Meri S, Käyhty H, Väkeväinen M (2010) The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement. Infect Immun 78: 5262-5270. doi:10.1128/IAI.00740-10. PubMed: 20855513.
49. Sandgren A, Sjöström K, Liljequist BO, Christensson B, Samuelsson A et al. (2004) Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis 189: 785-796. doi:10.1086/381686. PubMed: 14976594. (Pubitemid 38328178)
50. Hyams C, Trzcinski K, Camberlein E, Weinberger DM, Chimalapati S et al. (2013) Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b/iC3b. Infect Immun 81: 354-363. doi:10.1128/IAI.00862-12. PubMed: 23147038.
51. Rennels MB, Edwards KM, Keyserling HL, Reisinger KS, Hogerman DA et al. (1998) Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics 101: 604-611. doi:10.1542/peds.101.4.604. PubMed: 9521941. (Pubitemid 28180141)
52. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH et al. (2010) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201: 32-41. doi:10.1086/648593. PubMed: 19947881.
53. Miller E, Andrews NJ, Waight PA, Slack MP, George RC (2011) Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 11: 760-768. doi:10.1016/S1473-3099(11)70090-1. PubMed: 21621466.